Quentin has special expertise in small molecule design using in silico methods including molecular modeling, docking studies and molecular optimization and organic synthesis such as multistep synthesis, library generation and structural characterization. He has worked on a variety of drug discovery projects focused on addressing antibacterial resistance in Gram-negative bacteria and developing SARS-CoV-2 antivirals.
Education
- Doctor of Philosophy, Organic Chemistry, University of Oklahoma
- Master of Science, Organic Chemistry, University of Oklahoma
- Master of Engineering, Chemical Engineering, SIGMA Clermont, France
Honors and Awards
- COVID-19-Related Rapid Response Research Seed Grant 2020
- Program Fellow, Oklahoma Catalyst Researchers 2018
Publications & Presentations
- Structure-Uptake Relationship Studies of Oxazolidinones in Gram-negative ESKAPE Pathogens, Journal of Medicinal Chemistry, 2022
- A Multi-Approach Strategy to Improve the Spectrum of ClpP Activators, American Chemical Society, Spring 2019 National Meeting, Presenter
- Recent Advances Towards Rational Antibacterial Discovery Addressing Permeation and Efflux, Vol. 52, Medicinal Chemistry Reviews, 2017
